Immunome Inc. Files 8-K on Operations and Financials
Ticker: IMNM · Form: 8-K · Filed: May 12, 2025 · CIK: 1472012
| Field | Detail |
|---|---|
| Company | Immunome Inc. (IMNM) |
| Form Type | 8-K |
| Filed Date | May 12, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: operations, financials, filing
TL;DR
Immunome Inc. filed an 8-K on May 12, 2025, detailing operational and financial updates as of May 8, 2025.
AI Summary
Immunome, Inc. filed an 8-K on May 12, 2025, reporting on events that occurred on May 8, 2025. The filing pertains to results of operations, financial condition, and other events, including financial statements and exhibits. The company is incorporated in Delaware and headquartered in Bothell, WA.
Why It Matters
This 8-K filing provides an update on Immunome Inc.'s operational and financial status, which is crucial for investors to assess the company's performance and future prospects.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting operational and financial information, not indicating any immediate or significant risk event.
Key Players & Entities
- Immunome, Inc. (company) — Registrant
- Delaware (jurisdiction) — State of incorporation
- Bothell, WA (location) — Principal executive offices
- May 8, 2025 (date) — Earliest event reported
- May 12, 2025 (date) — Filing date
FAQ
What specific financial results or operational updates are detailed in this 8-K filing?
The filing indicates it pertains to 'Results of Operations and Financial Condition' and 'Other Events', but the specific details are not provided in the header information.
When was the earliest event reported in this Form 8-K?
The earliest event reported was on May 8, 2025.
What is the filing date of this 8-K report?
This 8-K report was filed on May 12, 2025.
Where are Immunome, Inc.'s principal executive offices located?
Immunome, Inc.'s principal executive offices are located at 18702 N. Creek Parkway, Suite 100, Bothell, WA 98011.
What is the Commission File Number for Immunome, Inc.?
The Commission File Number for Immunome, Inc. is 001-39580.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 12, 2025 regarding Immunome Inc. (IMNM).